# Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

> **NCT06864481** · — · RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 250 (estimated)

## Conditions studied

- Liver Injury
- Secondary to Immune Checkpoint Inhibitors
- Cancer Patients

## Interventions

- **OTHER:** Blood samples

## Key facts

- **NCT ID:** NCT06864481
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-22
- **Primary completion:** 2028-04-22
- **Final completion:** 2028-04-22
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06864481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06864481, "Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06864481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*